These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 30559133)

  • 41. Return of chloroquine-sensitive Plasmodium falciparum parasites and emergence of chloroquine-resistant Plasmodium vivax in Ethiopia.
    Mekonnen SK; Aseffa A; Berhe N; Teklehaymanot T; Clouse RM; Gebru T; Medhin G; Velavan TP
    Malar J; 2014 Jun; 13():244. PubMed ID: 24964730
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Molecular Markers of
    Osarfo J; Tagbor H; Magnussen P; Alifrangis M
    Am J Trop Med Hyg; 2018 Jun; 98(6):1714-1717. PubMed ID: 29582732
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Absence of in vivo selection for K13 mutations after artemether-lumefantrine treatment in Uganda.
    Balikagala B; Mita T; Ikeda M; Sakurai M; Yatsushiro S; Takahashi N; Tachibana SI; Auma M; Ntege EH; Ito D; Takashima E; Palacpac NM; Egwang TG; Onen JO; Kataoka M; Kimura E; Horii T; Tsuboi T
    Malar J; 2017 Jan; 16(1):23. PubMed ID: 28068997
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Efficacy and safety of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria and prevalence of molecular markers associated with artemisinin and partner drug resistance in Uganda.
    Ebong C; Sserwanga A; Namuganga JF; Kapisi J; Mpimbaza A; Gonahasa S; Asua V; Gudoi S; Kigozi R; Tibenderana J; Bwanika JB; Bosco A; Rubahika D; Kyabayinze D; Opigo J; Rutazana D; Sebikaari G; Belay K; Niang M; Halsey ES; Moriarty LF; Lucchi NW; Souza SSS; Nsobya SL; Kamya MR; Yeka A
    Malar J; 2021 Dec; 20(1):484. PubMed ID: 34952573
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Surveillance of genetic markers associated with Plasmodium falciparum resistance to artemisinin-based combination therapy in Pakistan, 2018-2019.
    Khan AQ; Pernaute-Lau L; Khattak AA; Luijcx S; Aydin-Schmidt B; Hussain M; Khan TA; Mufti FU; Morris U
    Malar J; 2020 Jun; 19(1):206. PubMed ID: 32513171
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Molecular surveillance of chloroquine drug resistance markers (Pfcrt and Pfmdr1) among imported Plasmodium falciparum malaria in Qatar.
    Acharya A; Bansal D; Bharti PK; Khan FY; Abusalah S; Elmalik A; ElKhalifa M; Mohapatra PK; Mahanta J; Sehgal R; Singh N; Sultan AA
    Pathog Glob Health; 2018 Mar; 112(2):57-62. PubMed ID: 29125042
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A comprehensive survey of polymorphisms conferring anti-malarial resistance in Plasmodium falciparum across Pakistan.
    Khattak AA; Venkatesan M; Jacob CG; Artimovich EM; Nadeem MF; Nighat F; Hombhanje F; Mita T; Malik SA; Plowe CV
    Malar J; 2013 Aug; 12():300. PubMed ID: 23988011
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Temporal changes in Plasmodium falciparum anti-malarial drug sensitivity in vitro and resistance-associated genetic mutations in isolates from Papua New Guinea.
    Koleala T; Karl S; Laman M; Moore BR; Benjamin J; Barnadas C; Robinson LJ; Kattenberg JH; Javati S; Wong RP; Rosanas-Urgell A; Betuela I; Siba PM; Mueller I; Davis TM
    Malar J; 2015 Jan; 14():37. PubMed ID: 25626445
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Ex vivo susceptibility of Plasmodium falciparum to antimalarial drugs in Northern Uganda.
    Fukuda N; Tachibana SI; Ikeda M; Sakurai-Yatsushiro M; Balikagala B; Katuro OT; Yamauchi M; Emoto S; Hashimoto M; Yatsushiro S; Sekihara M; Mori T; Hirai M; Opio W; Obwoya PS; Auma MA; Anywar DA; Kataoka M; Palacpac NMQ; Odongo-Aginya EI; Kimura E; Ogwang M; Horii T; Mita T
    Parasitol Int; 2021 Apr; 81():102277. PubMed ID: 33370608
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Molecular assessment of Plasmodium falciparum resistance to antimalarial drugs in Papua New Guinea using an extended ligase detection reaction fluorescent microsphere assay.
    Wong RP; Karunajeewa H; Mueller I; Siba P; Zimmerman PA; Davis TM
    Antimicrob Agents Chemother; 2011 Feb; 55(2):798-805. PubMed ID: 21078925
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Intermittent Preventive Treatment with Dihydroartemisinin-Piperaquine in Ugandan Schoolchildren Selects for Plasmodium falciparum Transporter Polymorphisms That Modify Drug Sensitivity.
    Nankabirwa JI; Conrad MD; Legac J; Tukwasibwe S; Tumwebaze P; Wandera B; Brooker SJ; Staedke SG; Kamya MR; Nsobya SL; Dorsey G; Rosenthal PJ
    Antimicrob Agents Chemother; 2016 Oct; 60(10):5649-54. PubMed ID: 27401569
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Modulation of in vitro antimalarial responses by polymorphisms in Plasmodium falciparum ABC transporters (pfmdr1 and pfmdr5).
    Gendrot M; Wague Gueye M; Tsombeng Foguim F; Madamet M; Wade KA; Bou Kounta M; Fall M; Diawara S; Benoit N; Lo G; Bercion R; Amalvict R; Mosnier J; Fall B; Briolant S; Diatta B; Pradines B
    Acta Trop; 2019 Aug; 196():126-134. PubMed ID: 31108084
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Molecular Evidence for
    Wedam J; Tacoli C; Gai PP; Siegert K; Kulkarni SS; Rasalkar R; Boloor A; Jain A; Mahabala C; Baliga S; Shenoy D; Devi R; Gai P; Mockenhaupt FP
    Am J Trop Med Hyg; 2018 Dec; 99(6):1508-1510. PubMed ID: 30398146
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Markers of anti-malarial drug resistance in Plasmodium falciparum isolates from Swaziland: identification of pfmdr1-86F in natural parasite isolates.
    Dlamini SV; Beshir K; Sutherland CJ
    Malar J; 2010 Mar; 9():68. PubMed ID: 20199676
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Molecular monitoring of Plasmodium falciparum drug susceptibility at the time of the introduction of artemisinin-based combination therapy in Yaoundé, Cameroon: implications for the future.
    Menard S; Morlais I; Tahar R; Sayang C; Mayengue PI; Iriart X; Benoit-Vical F; Lemen B; Magnaval JF; Awono-Ambene P; Basco LK; Berry A
    Malar J; 2012 Apr; 11():113. PubMed ID: 22498364
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Polymorphisms in K13, pfcrt, pfmdr1, pfdhfr, and pfdhps in parasites isolated from symptomatic malaria patients in Burkina Faso.
    Somé AF; Sorgho H; Zongo I; Bazié T; Nikiéma F; Sawadogo A; Zongo M; Compaoré YD; Ouédraogo JB
    Parasite; 2016; 23():60. PubMed ID: 28004634
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Molecular Mechanisms of Drug Resistance in
    Wicht KJ; Mok S; Fidock DA
    Annu Rev Microbiol; 2020 Sep; 74():431-454. PubMed ID: 32905757
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Monitoring of in vitro susceptibilities and molecular markers of resistance of Plasmodium falciparum isolates from Thai-Myanmar border to chloroquine, quinine, mefloquine and artesunate.
    Chaijaroenkul W; Wisedpanichkij R; Na-Bangchang K
    Acta Trop; 2010 Feb; 113(2):190-4. PubMed ID: 19879850
    [TBL] [Abstract][Full Text] [Related]  

  • 59.
    Montenegro M; Neal AT; Posada M; De Las Salas B; Lopera-Mesa TM; Fairhurst RM; Tobon-Castaño A
    Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28947476
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Genetic mutations in pfcrt and pfmdr1 at the time of artemisinin combination therapy introduction in South Pacific islands of Vanuatu and Solomon Islands.
    Gresty KJ; Gray KA; Bobogare A; Taleo G; Hii J; Wini L; Cheng Q; Waters NC
    Malar J; 2014 Oct; 13():406. PubMed ID: 25318907
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.